Bull
$67.03
Scenario price
$39.060
+0.652 (+1.67%)At close
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
RELX PLC is a good buy right now due to its current price of $36.13, which is well below the analyst price targets of £3,500 and £3,000, indicating significant upside potential. The company reported a 3% revenue growth to £4.87 billion in the first half of 2026, alongside an 8% increase in earnings per share, reflecting strong financial performance. However, the main risk is its year-to-date change of -9.22%, which indicates some volatility in the stock's performance.
BofA
—
2026-09-29
BofA
2026-09-29
Price Target
—
TD Cowen
—
2026-09-10
TD Cowen
2026-09-10
Price Target
—
Barclays
—
2026-07-24
Barclays
2026-07-24
Price Target
—
BofA
—
2026-07-24
BofA
2026-07-24
Price Target
—
Morgan Stanley
—
2026-05-07
Morgan Stanley
2026-05-07
Price Target
—
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

SNAP Agencies Face Record Fraud Costs, Study Finds

Latest Wall Street Ratings Overview

Brightmine Enhances HR Compliance Intelligence

RELX Reports 3% Revenue Growth to £4.87B in 1H

RELX Plc Reports Significant Profit Growth in H1 2026
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).
RELX PLC is a good buy right now due to its current price of $36.13, which is well below the analyst price targets of £3,500 and £3,000, indicating significant upside potential. The company reported a 3% revenue growth to £4.87 billion in the first half of 2026, alongside an 8% increase in earnings per share, reflecting strong financial performance. However, the main risk is its year-to-date change of -9.22%, which indicates some volatility in the stock's performance.
1 analysts cover RELX: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 60.54.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.